Reference Article

from Wikipedia, the free encyclopedia

Antiviral drug

Antiviral drugs are a class of medication used specifically for treating viral infections.

Like antibiotics, specific antivirals are used for specific viruses.

Antiviral drugs are one class of antimicrobials, a larger group which also includes antibiotics, anti-fungal and anti-parasitic drugs.

They are relatively harmless to the host, and therefore can be used to treat infections.

Note: This article excerpts material from the Wikipedia article "Antiviral drug", which is released under the GNU Free Documentation License.

See the following related content on ScienceDaily:


Related Videos

last updated on 2015-03-30 at 3:49 pm EDT

U.S. Ebola Patient Critical, To Be Given Experimental Drug

U.S. Ebola Patient Critical, To Be Given Experimental Drug

Newsy (Oct. 6, 2014) Thomas Duncan's condition worsened over the weekend. Now, the FDA has given the hospital permission to give Duncan an experimental antiviral drug. Video provided by Newsy
Powered by NewsLook.com
Federal Government Needs More Marijuana for Research Studies

Federal Government Needs More Marijuana for Research Studies

TheStreet (May 9, 2014) The National Institute for Drug Abuse, or NIDA, has asked the Drug Enforcement Agency for more marijuana. NIDA has requested an increase from 21,000 grams to 650,000 grams, or roughly 1,433 pounds of pot. As of January, NIDA has funded 28 active grants related to therapeutic uses of marijuana in six different disease categories covering AIDS, pain, schizophrenia, seizures and hard drug withdrawal. But NIDA frequently contradicts on the subject of marijuana: a NIDA-funded study at Yale looking at cannabis as a treatment for schizophrenia warned that marijuana could worsen the condition. NIDA gets its pot from The University of Mississippi, the only legal marijuana farm that grows pot for the government. The request is now open to the public for comment. Video provided by TheStreet
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
Pfizer Needs AstraZeneca More Than Ever as Generics Increase

Pfizer Needs AstraZeneca More Than Ever as Generics Increase

TheStreet (May 5, 2014) Pfizer shares are slipping after the drug maker posted first-quarter profits 15% lower than a year earlier and revenue down 9%. Net income of 57 cents a share beat expectations by 2 cents, but $11.3 billion in sales fell short of analysts' estimates of $12.1 billion. The weaker-than-expected report comes days after its latest offer to purchase British drug maker AstraZeneca for $106 billion was rejected. Pfizer has seen lost profits on greater competition from generic brands on the market. Video provided by TheStreet
Powered by NewsLook.com

Related Stories


Share This



Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins